Top Stories

Aspirin does not improve survival for Covid patients: UK study


A patient suffering from COVID-19 receives treatment at the coronavirus disease (COVID-19) Intensive Care Unit (ICU) of the “Klinikum Darmstadt” clinic in Darmstadt, Germany, May 20, 2021.

Kai Pfaffenbach | Reuters

LONDON — The cheap and widely-available drug aspirin does not improve survival for patients hospitalized with Covid-19, a U.K. study has found.

Oxford University researchers had hoped to find that the blood-thinning medicine could help hospitalized Covid-19 patients who are at an increased risk of clots forming in their blood vessels, particularly in the lungs, but found aspirin didn’t help to prevent deaths.

The study — part of a wider “RECOVERY” trial investigating various…


0 0 votes
Article Rating

Anthony Scaramucci on bitcoin and its potential to replace gold

Previous article

Americans willing to take on debt in a post-pandemic spending splurge

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Top Stories